Lupus Nephritis: Hopes, Questions Arise for Baricitinib : vi

Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of lupus nephritis.

Related Keywords

Italy , United States , Monash , South Australia , Australia , Egypt , Melbourne , Victoria , Milan , Lombardia , Ericf Morand , Manal Hassanien , Eli Lilly , European Alliance Of Associations , Therapeutics Department At Assiut University , Monash Health Rheumatology Unit , Rheumatology Research , European Alliance , Advanced Therapeutics Department , Assiut University , Systemic Lupus Erythematosus , Sale , Lupus Nephritis , Jak Stat , Ak Stat Signaling Pathway , Ak Stat Cytokine Receptors , Lupus , Dermatitis , Nephritis , Europe , European , Proteinuria , End Stage Renal Disease Esrd , End Stage Renal Disease , Srd , Rheumatoid Arthritis , A , Alopecia , Alopecia Areata ,